0.55
0.55 (0%)
As of Apr 17, 2025
Biodesix Inc [BDSX]
Source:
Company Overview
Biodesix Inc is a leading diagnostic solutions company and our mission is to transform patient care and improve outcomes through personalized diagnostics that are timely, accessible, and address immediate clinical needs. We envision a world where patient disease is conquered through the guidance of personalized diagnostics.
| Country | United States |
| Headquarters | boulder, colorado |
| Phone Number | 303-417-0500 |
| Industry | services |
| CEO | Scott Hutton |
| Website | biodesix.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $71.3 |
| Operating Profit | $-34.5 |
| Net Income | $-42.9 |
| Net Cash | $-0 |
Profit Ratios
| Gross Margin | $71.3 |
| Operating Margin | -48.4 |
| Profit as % of Revenues | -166.1% |
| Profit as % of Assets | -43.7% |
| Profit as % of Stockholder Equity | -205.7% |
Management Effectiveness
| Return on Equity | -205.7% |
| Return on Assets | -44.2% |
| Turnover Ratio | 72.7% |
| EBITA | $-34.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $97.2 |
| Total Liabilities | $76.4 |
| Operating Cash Flow | $-48.6 |
| Investing Cash Flow | $-3.4 |
| Financing Cash Flow | $52.1 |
